Osborne Clarke advises medical device company Creo Europe on sale of 51% stake to China-based Micro-Tech
International legal practice Osborne Clarke has advised Creo Medical Group plc on its entry into a binding agreement for the...
Published on
20/09/2024
Read time
1m